Stocks
Revance Therapeutics, Inc.RVNC
NASDAQHealthcareBiotechnology$3.65+0.00%
Develops and commercializes injectable neuromodulators and dermal fillers used in aesthetic and therapeutic medicine. Revance Therapeutics markets Daxxify, a long-acting botulinum toxin product positioned to compete with established brands such as AbbVie’s Botox in the medical aesthetics market, and...
Market Cap: $381.0M52W Range: $2.30 – $7.56
Congressional Interest in Revance Therapeutics, Inc. (RVNC)
1 member of Congress has disclosed 1 trade in Revance Therapeutics, Inc. (RVNC), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading RVNC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-10-04 | Thomas R Carper | buy | $1K – $15K |